Data di Pubblicazione:
2009
Abstract:
To identify the clinical factors predicting failure or a good clinical response in the cohort of RA patients entered in the Lombardy Rheumatology Network (LORHEN) registry after 3 years of treatment with anti-TNF agents.
Tipologia CRIS:
14.a.1 Articolo su rivista
Keywords:
EULAR response; DAS-28 response; Factor predictors; Anti-TNF; LORHEN registry; Adalimumab; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Rheumatoid; Etanercept; Female; Follow-Up Studies; Humans; Immunoglobulin G; Infliximab; Male; Middle Aged; Receptors, Tumor Necrosis Factor; Remission Induction; Risk Factors; Severity of Illness Index; Sex Factors; Treatment Outcome; Tumor Necrosis Factor-alpha
Elenco autori:
Atzeni, Fabiola; Antivalle, Marco; Pallavicini, Francesca Bobbio; Caporali, Roberto; Bazzani, Chiara; Gorla, Roberto; Favalli, Ennio Giulio; Marchesoni, Antonio; Sarzi-Puttini, Piercarlo
Link alla scheda completa:
Pubblicato in: